Schizophrenia (SZ) is a highly heritable psychiatric disorder with recognized neurodevelopmental origins and substantial effects on cognition. Prior work has reported alterations in the ubiquitin system in SZ, but the contribution of common genetic variation within ubiquitin system genes (USG) to SZ susceptibility and cognitive heterogeneity remained unclear. The study aimed to test whether common SZ-associated variation is enriched within USG, whether enrichment varies by spatiotemporal brain expression, and whether a polygenic burden within this system relates to cognitive performance.
The investigators assembled a Gene Ontology-based panel comprising 1,450 autosomal ubiquitin system genes (the global USG panel, or gUSG). This panel served as the target gene set for enrichment analyses to determine whether common variation associated with SZ is overrepresented in USG relative to expectation. The enrichment of SZ-associated variation within the gUSG was explicitly tested; details of statistical thresholds and exact enrichment metrics were reported in the source article.
Polygenic scores (PGS) derived from the gUSG were calculated in a case-control cohort including 183 individuals diagnosed with SZ and 127 healthy controls (HC). The PGS approach aggregated common genetic variation within the defined USG panel to quantify per-individual polygenic burden. The report states these PGS were compared between cases and controls to assess whether individuals with SZ carry an elevated polygenic burden within ubiquitin system genes.
To evaluate whether the contribution of USG variation depends on developmental timing and brain region, the authors used BrainSpan expression data to stratify the gUSG into subpanels. Stratification was performed by developmental stage (prenatal versus postnatal) and by brain region, with focused analyses on the prefrontal cortex and the cerebellum. These stratified PGS panels enabled assessment of whether prenatal expression or region-specific expression patterns of USG were particularly implicated in SZ-associated polygenic burden.
Cognitive evaluation included measures of premorbid and current intelligence quotient (IQ), memory, and executive function tests. The study tested associations between the various USG-derived PGS (global and stratified panels) and these cognitive domains, both in the overall sample and specifically within the SZ group, to explore whether polygenic burden in the ubiquitin system relates to cognitive heterogeneity in SZ.
The authors report that USG were enriched for SZ-associated common variation. Individuals with SZ showed a higher polygenic burden within the global USG panel compared with healthy controls. Among the stratified analyses, the strongest associations involved USG expressed during prenatal development, especially those expressed in the prefrontal cortex. The cerebellar and postnatal stratified panels were analyzed but the strongest signal reported was prenatal–prefrontal.
Within the SZ group, a higher gUSG-PGS was associated with lower premorbid and current IQ. Additionally, the prenatal–prefrontal PGS was associated with poorer memory performance. Executive function associations were assessed as part of the cognitive battery; the summary emphasizes the IQ and memory findings as the main cognitive associations reported.
These findings support a role for ubiquitin system genes in the genetic architecture of schizophrenia and suggest that common variation within this pathway may link genetic susceptibility to prenatal neurodevelopmental processes, particularly in the prefrontal cortex, and to cognitive heterogeneity observed in SZ. The results are consistent with a model in which dysregulation of ubiquitin-related processes during prenatal brain development contributes to later disorder risk and cognitive outcomes.
This work is reported as a preprint and has not been peer reviewed; the authors caution that the findings should not be used to guide clinical practice. The article provides no additional independent replication cohort within the source text; further validation would be required. The data supporting the findings are available from the corresponding authors upon reasonable request, as stated in the source.
Ethical approval was obtained from FIDMAG Hermanas Hospitalarias and Fundacio Sant Joan de Deu Research Ethics Committees, and all participants provided written informed consent. The authors declared no competing interests. Funding sources and grant identifiers supporting the work are reported in the source document. The preprint includes links to supplementary material and data/code resources as noted by the authors.